Trimtech Therapeutics

Investor: Johnson & Johnson Innovation – JJDC, BGF

Trimtech Therapeutics has raised an additional £10.6m in seed funding, bringing the total for the round to £35.6m. Summary of transaction details: Value: £35.6m Sector: Healthcare & Biotech Advisor: Not disclosed Key Entities: Trimtech Therapeutics, Johnson & Johnson Innovation – JJDC, BGF Location: Not disclosed Note: The funding will support Trimtech Therapeutics as it progresses its proprietary platforms and differentiated portfolio, aiming to transform the course of treatment for neurodegenerative and inflammatory diseases.

Investor: Start Codon, Eli lilly and company, Pfizer Ventures, Cambridge Enterprise Ventures, MP Healthcare Venture Management, Dementia Discovery Fund, M Ventures, Cambridge Innovation Capital